InvestorsHub Logo

__SmartMoney__

04/11/24 4:44 AM

#65444 RE: hardlesson #65443

I noticed that. It's good they have started to open up a little and allow people to respond to their posts.

ChartTRACKER

04/12/24 12:55 PM

#65478 RE: hardlesson #65443

$SHMN: HL: Anyone with access to SoHM...Please pass this on to Aguilar & Gallegos...ASAP

1. Electroporation alters Phenotypes & also does NOT offer the highest yields to
a. Cell Health
b. Maximizing Payload ["Viral Vector"]
c. Efficiency & Yield of Payload Delivery

Have you looked at cutting edge alternatives to Electroporation? Why constrain yourself to Old-Tech?
Maybe get a FREE TRIAL [for data generation from👇️]
https://www.cellfebiotech.com/how-it-works/
I have NO affiliation to 👆️
2. If you're using a FACS type cell sorter [per your poster] for CD34, then you would be prone to a certain % of error due to
Phenotype changes.

If you need to know who I am...we'll talk thro' Julio M Clark.

And Pls...F*ing publish a Hi-RES POSTER of what you presented at AACR! WTF is Barron trying to hide here!
WTF is your mkt-ing dept doing? Twiddling thumbs?

hardlesson

04/15/24 10:13 AM

#65497 RE: hardlesson #65443

Tweet/Link to article on Linkedin:

https://www.linkedin.com/pulse/9-pharmaceutical-treatment-trends-shaping-future-whats-next-xtqcc/?trackingId=lJfQR8ALRUCDTnOGr64QPA%3D%3D

hL shmn